Úsek pro vědu a výzkum

Impaktované publikace

[1]

Vydra, J.; Shanley, R.M.; George, I.; Ustun, C.; et al.

Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation

[rok vydání 2018, impact factor 9.374 ]

[2]

Folta, A.; Culen, M.; Jeziskova, I.; Herudkova, Z.; Tom, N.; Hlubinkova, T.; Janeckova, V.; Durinikova, A.; Vydra, J.; Semerad, L.; Dvorakova, D.; Remesova, H.; Cerovska, E.; Cetkovsky, P.; et al.

Prognostic significance of mutation profile at diagnosis and mutation persistence during disease remission in adult acute myeloid leukaemia patients

[rok vydání 2019, impact factor 5.518 ]

[3]

McLornan, D.; Eikema, D.J.; Czerw, T.; Kröger, N.; Koster, L.; Reinhardt, H.C.; Angelucci, E.; Robin, M.; Bornhäuser, M.; Passweg, J.; Clark, A.; Vydra, J.; et al.

Trends in allogeneic haematopoietic cell transplantation for myelofibrosis in Europe between 1995 and 2018: a CMWP of EBMT retrospective analysis

[rok vydání 2021, impact factor 5.483 ]

[4]

Šťastná Marková, M.; Hamšíková, E.; Hainz, P.; Hubáček, P.; Kroutilová, M.; Kryštofová, J.; Ludvíková, V.; Musil, J.; Pecherková, P.; Saláková, M.; Šroller, V.;

Pretransplant BK virus-specific T-cell-mediated immunity and serotype specific antibodies may have utility in identifying patients at risk of BK virus-associated haemorrhagic cystitis after allogeneic HSCT

[rok vydání 2021, impact factor 4.422 ]

[5]

Ustun, C.; Slabý, J.; Shanley, R.M.; Vydra, J.; et al.

Human parainfluenza virus infection after hematopoietic stem cell transplantation: risk factors, management, mortality, and changes over time

[rok vydání 2018, impact factor 3.940 ]

[6]

Sarova, I.; Brezinova, J.; Zemanova, Z.; Bystricka, D.; Krejcik, Z.; Soukup, P.; Cetkovsky, P.; Vydra, J.; Cermak, J.; Jonasova, A.; Michalova, K.

Characterization of chromosome 11 breakpoints and the areas of deletions and amplifications in newly diagnosed acute myeloid leukemia

[rok vydání 2012, impact factor 3.836 ]

[7]

Nemeckova, S.; Alexova-Zurkova, K.; Hainz, P.; Krystofova, J.; Mackova, J.; Roubalova, K.; Stastna-Markova, M.; Vrana, M.; Vydra, J.

Non-mutated nucleophosmin 1 is recognized by the CD8+ T lymphocytes of an AML patient after the transplantation of hematopoietic stem cells from an HLA-haploidentical donor

[rok vydání 2022, impact factor 3.677 ]

[8]

Šálek, C.; Vydra, J.; Cerovská, E.; Šestáková, Š.; Ransdorfová, Š.; Válková, V.; Cetkovský, P.; Remešová, H.

WT1 expression in peripheral blood at diagnosis and during the course of early consolidation treatment correlates with survival in patients with intermediate and poor-risk acute myeloid leukemia

[rok vydání 2020, impact factor 3.231 ]

[9]

Valkova, V.; Vydra, J.; Markova, M.; Cerovska, E.; Vrana, M.; Marinov, I.; Cechova, H.; Cetkovsky, P.; Vitek, A.; Salek, C.

WT1 gene expression in peripheral blood before and after allogeneic stem cell transplantation is a clinically relevant prognostic marker in AML: a single-center 14-year experience

[rok vydání 2020, impact factor 3.231 ]

[10]

Pekova, S.; Vydra, J.; Kabickova, H.; et al.

Candidatus Neoehrlichia mikurensis infection identified in 2 hematooncologic patients: benefit of molecular techniques for rare pathogen detection

[rok vydání 2018, impact factor 2.528 ]

[11]

Racil, Z.; Weinbergerova, B.; Kocmanova, I.; Muzik, J.; Kouba, M.; Drgona, L.; Masarova, L.; Guman, T.; Tothova, E.; Forsterova, K.; Haber, J.; Ziakova, B.; Bojtarova, E.; Vydra, J.; Mudry, P.; Foralova, R.; Sejnova, D.; Mallatova, N.; Kandrnal, V.; Cetkovsky, P.; Mayer, J.

Invasive aspergillosis in patients with hematological malignancies in the Czech and Slovak Republics: Fungal InfectioN Database (FIND) analysis, 2005-2009

[rok vydání 2012, impact factor 2.330 ]

[12]

Vydra, J.; Válková, V.; Čemusová, B.; Kolář, M.; Nováková, L.; Soukup, P.; Šálek, C.; Vraná, M.; Pytlík, R.; Lesný, P.; Vítek, A.; Cetkovský, P.; Marková, M.

Hematopoietic stem cell transplantation from haploidentical donors in aplasia after cladribine/cytarabine chemotherapy for refractory acute myeloid leukemia or myelodysplastic syndrome

[rok vydání 2019, impact factor 2.298 ]

[13]

Vydra, J.; Šálek, C.; Schwarz, J.; Žák, P.; Novák, J.; Petečuková, V.; Pecherková, P.; Mayer, J.; Cetkovský, P.; Ráčil, Z.

Analysis of real-world data on postremission therapy for acute myeloid leukemia with intermediate risk cytogenetics in first complete remission

[rok vydání 2017, impact factor 2.274 ]

[14]

Tesfaye, H.; Branová, R.; Říha, P.; Sedláček, P.; Vydra, J.

Current challenges of body weight based intravenous busulfan dosing versus dose adjustment based on therapeutic drug monitoring

[rok vydání 2014, impact factor 0.441]

Neimpaktované publikace

[1]

Vydra, J.; Mayer, J.; Starý, J.; Ráčil, Z.

Akutní myeloidní leukemie

[rok vydání 2016]